Dossier
Karim Mikhail
Coverage of Karim Mikhail in the Nexus archive.
- STAT+: Under a new leader, the FDA’s biologics center moves to steady itself after stormy chapter
Karim Mikhail, acting director of the FDA’s Center for Biologics Evaluation and Research, addressed staff to emphasize his connection to their experiences, following the unconventional leadership of his predecessor Vinay Prasad. The center is working to stabilize after a period described as 'stormy.'